Anders Jack, CFO of Revolution Medicines, Inc. ($RVMD), made nine open market sales of company shares over the past year, totaling $2.93 million. His most recent sale occurred on January 7, 2026. These transactions rank 2,770th among 11,678 insiders in our database, trailing the average sale value of $8.6 million across about 6.4 transactions per insider. He reported no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 17, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 2753 | $99.48 | 125,512.0000 | 193,319,805 | 2.15% | 0.00% |
| March 1, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Stock Option (Right to Buy) | 45400 | $0.00 | 45,400.0000 | 193,319,805 | 9999.99% | 0.02% |
| March 1, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Common Stock | 20200 | $0.00 | 128,265.0000 | 193,319,805 | 18.69% | 0.01% |
| Jan. 7, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 15,900.0000 | 193,319,805 | 38.61% | 0.01% |
| Jan. 7, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 10000 | $98.00 | 108,065.0000 | 193,319,805 | 8.47% | 0.01% |
| Jan. 7, 2026 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 10000 | $42.45 | 118,065.0000 | 193,319,805 | 9.25% | 0.01% |
| Dec. 16, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 3104 | $77.09 | 108,065.0000 | 193,319,805 | 2.79% | 0.00% |
| Nov. 25, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 5418 | $17.00 | 116,412.0000 | 193,319,805 | 4.88% | 0.00% |
| Nov. 25, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 5418 | $74.00 | 110,994.0000 | 193,319,805 | 4.65% | 0.00% |
| Nov. 25, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 5418 | $0.00 | 0.0000 | 193,319,805 | 100.00% | 0.00% |
| Nov. 11, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 10000 | $17.00 | 120,994.0000 | 193,319,805 | 9.01% | 0.01% |
| Nov. 11, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 5,418.0000 | 193,319,805 | 64.86% | 0.01% |
| Nov. 11, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 10000 | $64.00 | 110,994.0000 | 193,319,805 | 8.26% | 0.01% |
| Sept. 16, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 2320 | $45.82 | 110,994.0000 | 185,913,326 | 2.05% | 0.00% |
| Sept. 3, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 2049 | $0.00 | 15,418.0000 | 185,913,326 | 11.73% | 0.00% |
| Sept. 3, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 3189 | $0.00 | 0.0000 | 185,913,326 | 100.00% | 0.00% |
| Sept. 2, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 2814 | $2.68 | 116,128.0000 | 185,913,326 | 2.48% | 0.00% |
| Sept. 2, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 1948 | $4.73 | 118,076.0000 | 185,913,326 | 1.68% | 0.00% |
| Sept. 2, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 4762 | $40.02 | 113,314.0000 | 185,913,326 | 4.03% | 0.00% |
| Sept. 3, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 3189 | $4.73 | 116,503.0000 | 185,913,326 | 2.81% | 0.00% |
| Sept. 3, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 2049 | $17.00 | 118,552.0000 | 185,913,326 | 1.76% | 0.00% |
| Sept. 3, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 5238 | $40.17 | 113,314.0000 | 185,913,326 | 4.42% | 0.00% |
| Sept. 2, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 1948 | $0.00 | 3,189.0000 | 185,913,326 | 37.92% | 0.00% |
| Sept. 2, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 2814 | $0.00 | 0.0000 | 185,913,326 | 100.00% | 0.00% |
| June 16, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 2170 | $39.83 | 113,314.0000 | 185,913,326 | 1.88% | 0.00% |
| March 17, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1864 | $39.04 | 115,006.0000 | 185,913,326 | 1.59% | 0.00% |
| March 1, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Stock Option (Right to Buy) | 71400 | $0.00 | 71,400.0000 | 185,913,326 | 9999.99% | 0.04% |
| March 1, 2025 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Common Stock | 20400 | $0.00 | 116,870.0000 | 185,913,326 | 21.15% | 0.01% |
| Dec. 16, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 2635 | $45.40 | 96,470.0000 | 0 | 2.66% | 0.00% |
| Oct. 11, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 10000 | $50.30 | 98,932.0000 | 0 | 9.18% | 0.00% |
| Oct. 11, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 10000 | $2.68 | 108,932.0000 | 0 | 10.11% | 0.00% |
| Oct. 11, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 2,814.0000 | 0 | 78.04% | 0.00% |
| Sept. 16, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 2244 | $44.19 | 98,932.0000 | 0 | 2.22% | 0.00% |
| June 17, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1893 | $37.39 | 101,176.0000 | 0 | 1.84% | 0.00% |
| May 3, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 10000 | $0.00 | 12,814.0000 | 0 | 43.83% | 0.00% |
| May 3, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 10000 | $2.68 | 111,959.0000 | 0 | 9.81% | 0.00% |
| May 3, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 10000 | $40.03 | 101,959.0000 | 0 | 8.93% | 0.00% |
| March 18, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1261 | $31.58 | 101,959.0000 | 0 | 1.22% | 0.00% |
| March 1, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Stock Option (Right to Buy) | 92400 | $0.00 | 92,400.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2024 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Common Stock | 26400 | $0.00 | 103,220.0000 | 0 | 34.37% | 0.00% |
| Dec. 18, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1775 | $25.90 | 76,416.0000 | 0 | 2.27% | 0.00% |
| Oct. 23, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 19387 | $0.00 | 22,814.0000 | 0 | 45.94% | 0.00% |
| Oct. 23, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 5137 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Oct. 23, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 19387 | $2.68 | 73,054.0000 | 0 | 36.12% | 0.00% |
| Oct. 23, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 5137 | $4.09 | 78,191.0000 | 0 | 7.03% | 0.00% |
| Sept. 18, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1427 | $31.31 | 53,667.0000 | 0 | 2.59% | 0.00% |
| Sept. 1, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Common Stock | 20000 | $2.68 | 75,094.0000 | 0 | 36.30% | 0.00% |
| Sept. 1, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 20000 | $35.05 | 55,094.0000 | 0 | 26.63% | 0.00% |
| Sept. 1, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | M | Stock Option (Right to Buy) | 20000 | $0.00 | 42,201.0000 | 0 | 32.15% | 0.00% |
| June 20, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 1249 | $24.89 | 55,094.0000 | 0 | 2.22% | 0.00% |
| March 17, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | S | Common Stock | 665 | $21.78 | 55,233.0000 | 0 | 1.19% | 0.00% |
| March 1, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Stock Option (Right to Buy) | 93100 | $0.00 | 93,100.0000 | 0 | 9999.99% | 0.00% |
| March 1, 2023 | Revolution Medicines, Inc. | $RVMD | Anders Jack | Chief Financial Officer | A | Common Stock | 26600 | $0.00 | 55,898.0000 | 0 | 90.79% | 0.00% |